Brenntag (FRA:BNR) PT Set at €99.00 by The Goldman Sachs Group

Brenntag (FRA:BNRGet Rating) received a €99.00 ($102.06) price target from analysts at The Goldman Sachs Group in a research note issued on Wednesday, Borsen Zeitung reports. The Goldman Sachs Group’s target price indicates a potential upside of 43.73% from the company’s previous close.

A number of other equities research analysts have also weighed in on the company. UBS Group set a €82.00 ($84.54) price target on Brenntag in a research note on Monday, July 4th. JPMorgan Chase & Co. set a €96.00 ($98.97) price target on Brenntag in a research note on Tuesday, June 14th. Barclays set a €95.00 ($97.94) price target on Brenntag in a research note on Friday, July 29th. Berenberg Bank set a €100.00 ($103.09) target price on Brenntag in a report on Wednesday, June 15th. Finally, Deutsche Bank Aktiengesellschaft decreased their target price on Brenntag from €99.00 ($102.06) to €88.00 ($90.72) in a report on Tuesday, July 19th.

Brenntag Trading Up 1.0 %

BNR opened at €68.88 ($71.01) on Wednesday. Brenntag has a 1 year low of €43.06 ($44.39) and a 1 year high of €56.25 ($57.99). The business’s 50-day moving average is €66.11 and its two-hundred day moving average is €70.87.

About Brenntag

(Get Rating)

Brenntag SE purchases and supplies various industrial and specialty chemicals, and ingredients in Europe, the Middle East, Africa, North America, Latin America, the Asia Pacific, and internationally. The company operates through the divisions Brenntag Essentials and Brenntag Specialties. It provides value-added services, such as just-in-time delivery, product mixing, blending, repackaging, inventory management, and drum return handling, as well as technical and laboratory services for specialty chemicals.

Recommended Stories

Receive News & Ratings for Brenntag Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Brenntag and related companies with MarketBeat.com's FREE daily email newsletter.